← Back to work
Works cited by this work
292 works
Work: CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer
Article20152 citationsABICXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion
Magda Kucia, Kacper Jankowski, Ryan Reca +6
Review article20042 citationsABICXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher, Simon P. Fricker
Review article20102 citationsABIThe significance of cancer cell expression of the chemokine receptor CXCR4
Review article20042 citationsABICXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
Xueqing Sun, Guangcun Cheng, Mingang Hao +6
Review article20102 citationsABIMolecular Pathways: Targeting the CXCR4–CXCL12 Axis—Untapped Potential in the Tumor Microenvironment
Review article20152 citationsABIInvolvement of chemokine receptors in breast cancer metastasis
Anja Müller, Bernhard Homey, Hortensia Soto +11
Article20012 citationsABISmall Molecule Inhibitors of CXCR4
Bikash Debnath, Shili Xu, Fedora Grande +2
Review article20132 citationsABITargeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
Weiqiang Zhou, Shanchun Guo, Mingli Liu +2
Review article20172 citationsABIRelevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditions
Christine Huynh, Jasper Dingemanse, Henriette E. Meyer zu Schwabedissen +1
Review article20202 citationsABIThe Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
Yi Shi, David J. Riese, Jianzhong Shen
Review article20202 citationsABI